Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial.

about

Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial.

Item

http://www.wikidata.org/entity/Q50089242

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Comparison of Self-report to B ...... Findings from the START Trial.

@en

Comparison of Self-report to B ...... Findings from the START Trial.

@nl

type

Item

label

Comparison of Self-report to B ...... Findings from the START Trial.

@en

Comparison of Self-report to B ...... Findings from the START Trial.

@nl

prefLabel

Comparison of Self-report to B ...... Findings from the START Trial.

@en

Comparison of Self-report to B ...... Findings from the START Trial.

@nl

P1476

Comparison of Self-report to B ...... Findings from the START Trial.

@en

P2093

Angie N Pinto

http://www.w3.org/2001/XMLSchema#string

Danielle German

http://www.w3.org/2001/XMLSchema#string

Giuseppe Tambussi

http://www.w3.org/2001/XMLSchema#string

INSIGHT START Study Group

http://www.w3.org/2001/XMLSchema#string

James D Neaton

http://www.w3.org/2001/XMLSchema#string

Julia A Metcalf

http://www.w3.org/2001/XMLSchema#string

Katherine E Schlusser

http://www.w3.org/2001/XMLSchema#string

Pola de la Torre

http://www.w3.org/2001/XMLSchema#string

Rika Draenert

http://www.w3.org/2001/XMLSchema#string

Shweta Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Global trends in molecular epidemiology of HIV-1 during 2000-2007.

Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository.

Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.

Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.

Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial

Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.

Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward.

Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes

P2888

s10461-018-2048-y

P31

scholarly article

P356

10.1007/S10461-018-2048-Y

http://www.w3.org/2001/XMLSchema#string

P50

Oliver Laeyendecker

P577

2018-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29427230

http://www.w3.org/2001/XMLSchema#string

P932

6021209

http://www.w3.org/2001/XMLSchema#string